It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

Maggie O’Neill is a health writer and reporter based in New York who specializes in covering medical research and emerging wellness trends, with a focus on cancer and addiction. Prior to her ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...